Dr. Petra Doerr, Deputy Executive Director of Swissmedic, and Dr. Murray Lumpkin, Deputy Director of Regulatory Affairs and Lead for Global Regulatory Systems Initiatives for the Bill and Melinda Gates Foundation, explain the World Health Organization’s <a href="http://apps.who.int/medicinedocs/en/d/Js23222en/" target="_blank">Essential Medicines and Health Products Strategic Framework for 2016 to 2030</a>.

Dr. Petra Doerr, Deputy Executive Director of Swissmedic, and Dr. Murray Lumpkin, Deputy Director of Regulatory Affairs and Lead for Global Regulatory Systems Initiatives for the Bill and Melinda Gates Foundation, explain the World Health Organization’s Essential Medicines and Health Products Strategic Framework for 2016 to 2030.

Dr. Petra Doerr, Deputy Executive Director of Swissmedic, and Dr. Murray Lumpkin, Deputy Director of Regulatory Affairs and Lead for Global Regulatory Systems Initiatives for the Bill and Melinda Gates Foundation, explain the World Health Organization’s <a href="http://apps.who.int/medicinedocs/en/d/Js23222en/" rel="noopener noreferrer">Essential Medicines and Health Products Strategic Framework for 2016 to 2030</a>.

WHO 2030 Framework for Efficient, Effective Regulation

DIA is a global, multidisciplinary, membership association of healthcare professionals that works towards the advancement of lifesaving medicines, therapies, and technologies around the world.

Share WHO 2030 Framework for Efficient, Effective Regulation

Sign up to save your podcasts

WHO 2030 Framework for Efficient, Effective Regulation

WHO 2030 Framework for Efficient, Effective Regulation